Product Information
POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by BioComp Pharma Inc., priced at $0.1742 per EA under NDC 44523041501. Its NADAC has been published 650 times since Apr 23, 2014.
FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 meq/1
Manufacturer
BioComp Pharma Inc.NDC
44523041501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019071FDA Approved
8/30/1985
TE Code
AB
On Market Since
12/23/2013
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 650 times since Apr 23, 2014, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1742 per EA |
|---|---|
| All-time high | $2.0475 (Jan 11, 2017) |
| All-time low | $0.1722 (Jul 17, 2024) |
| 52-week high | $0.2197 |
| 52-week low | $0.1742 |
| Median price | $1.1241 |
| Average price | $1.0878 |
| Largest weekly change | +69.2% (May 17, 2023) |
| Weeks tracked | 650 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BioComp Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium citrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by BioComp Pharma Inc., is $0.1742 per EA (NDC 44523041501), effective Sep 30, 2026.
How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 91.0%. It has been tracked across 650 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?
Since Apr 23, 2014, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $2.0475 (Jan 11, 2017), with a median of $1.1241 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?
POTASSIUM CITRATE ER 15 MEQ TB (NDC 44523041501) is labeled by BioComp Pharma Inc., and CMS classifies it as a generic product.